2024版CACA 胃癌整合诊治指南(精简版)

China Anti-Cancer Association guidelines for holistic integrative management of gastric cancer (2024 abridged version)

  • 摘要: 中国胃癌的高发病率与死亡率持续位居前列,探索并优化具有中国特色的“预防-筛查-诊断-治疗-康复”一体化管理策略,意义重大。在中国抗癌协会指导下,胃癌专业委员会基于前版指南,修订完成《2024版CACA胃癌整合诊治指南》。继续深化“全人、全身、全程、全息”的核心思想,进一步融合多学科团队向整合医学(MDT to HIM)的先进诊疗理念,紧密贴合中国人群的流行病学特性、遗传倾向、原创科研成就及独特的防控实践。本次修订特别注重吸纳国内最新研究成果,同时确保医疗服务的广泛可及性,既彰显中医药特色优势,又融入我国癌症防控的深厚经验,实现“研究证据、医生经验、患者需求”三者间和谐统一。旨在及时更新发布一部科学、规范且实用性强的诊疗指南,能够为全国医疗工作者提供有力的指导工具,助力中国胃癌防治工作更加精准高效,显著改善患者预后,为健康中国战略的深入实施贡献力量。

     

    Abstract: The incidence and mortality rates of gastric cancer in China remain high, highlighting the urgency to explore and optimize an integrated management strategy with Chinese characteristics that covers prevention, screening, diagnosis, treatment, and recovery. The integrative guidelines for gastric cancer were established by the Committee of Gastric Cancer under the guidance of the China Anti-Cancer Association (CACA), building on the previous edition. These guidelines enhance the core concepts of “whole person, whole body, whole journey, and whole information” and further integrate advanced diagnostic and treatment philosophies of multidisciplinary teams into holistic integrative medicine (MDT to HIM). They closely align with the epidemiological characteristics, genetic predispositions, original scientific research achievements, and unique prevention and control practices of the Chinese population. This revision places special emphasis on incorporating the latest domestic research findings while ensuring widespread accessibility to medical services. It show cases the unique advantages of traditional Chinese medicine while incorporating China’s extensive experience in cancer prevention and control, achieving a balanced integration of research evidence, physician experience, and patient needs. The release of these scientific, standardized, and highly practical diagnostic and treatment guidelines are anticipated to provide valuable guidance for medical professionals nationwide, contributing to more precise and efficient gastric cancer prevention and treatment efforts in China, significantly improving patient outcomes, and advancing the implementation of the Healthy China Initiative.

     

/

返回文章
返回